BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19281149)

  • 1. PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo.
    Steinmetz NF; Manchester M
    Biomacromolecules; 2009 Apr; 10(4):784-92. PubMed ID: 19281149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells.
    Destito G; Yeh R; Rae CS; Finn MG; Manchester M
    Chem Biol; 2007 Oct; 14(10):1152-62. PubMed ID: 17961827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral nanoparticles for in vivo tumor imaging.
    Wen AM; Lee KL; Yildiz I; Bruckman MA; Shukla S; Steinmetz NF
    J Vis Exp; 2012 Nov; (69):e4352. PubMed ID: 23183850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interior engineering of a viral nanoparticle and its tumor homing properties.
    Wen AM; Shukla S; Saxena P; Aljabali AA; Yildiz I; Dey S; Mealy JE; Yang AC; Evans DJ; Lomonossoff GP; Steinmetz NF
    Biomacromolecules; 2012 Dec; 13(12):3990-4001. PubMed ID: 23121655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo.
    Gonzalez MJ; Plummer EM; Rae CS; Manchester M
    PLoS One; 2009 Nov; 4(11):e7981. PubMed ID: 19956734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential uptake of chemically modified cowpea mosaic virus nanoparticles in macrophage subpopulations present in inflammatory and tumor microenvironments.
    Agrawal A; Manchester M
    Biomacromolecules; 2012 Oct; 13(10):3320-6. PubMed ID: 22963597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth.
    Nkanga CI; Steinmetz NF
    ACS Biomater Sci Eng; 2022 Jun; 8(6):2518-2525. PubMed ID: 35522951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of nanoparticle uptake in tumors in real time using intravital imaging.
    Cho CF; Ablack A; Leong HS; Zijlstra A; Lewis J
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of viral nanoparticles for efficient intracellular delivery.
    Wu Z; Chen K; Yildiz I; Dirksen A; Fischer R; Dawson PE; Steinmetz NF
    Nanoscale; 2012 Jun; 4(11):3567-76. PubMed ID: 22508503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly of multilayer arrays of viral nanoparticles via biospecific recognition: a quartz crystal microbalance with dissipation monitoring study.
    Steinmetz NF; Bock E; Richter RP; Spatz JP; Lomonossoff GP; Evans DJ
    Biomacromolecules; 2008 Feb; 9(2):456-62. PubMed ID: 18197628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin.
    Koudelka KJ; Destito G; Plummer EM; Trauger SA; Siuzdak G; Manchester M
    PLoS Pathog; 2009 May; 5(5):e1000417. PubMed ID: 19412526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cowpea mosaic virus nanoparticles for cancer imaging and therapy.
    Beatty PH; Lewis JD
    Adv Drug Deliv Rev; 2019 May; 145():130-144. PubMed ID: 31004625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X.
    Shukla S; Ablack AL; Wen AM; Lee KL; Lewis JD; Steinmetz NF
    Mol Pharm; 2013 Jan; 10(1):33-42. PubMed ID: 22731633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-atherogenic effect of trivalent chromium-loaded CPMV nanoparticles in human aortic smooth muscle cells under hyperglycemic conditions in vitro.
    Ganguly R; Wen AM; Myer AB; Czech T; Sahu S; Steinmetz NF; Raman P
    Nanoscale; 2016 Mar; 8(12):6542-54. PubMed ID: 26935414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocytic uptake pathways utilized by CPMV nanoparticles.
    Plummer EM; Manchester M
    Mol Pharm; 2013 Jan; 10(1):26-32. PubMed ID: 22905759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery.
    Yildiz I; Lee KL; Chen K; Shukla S; Steinmetz NF
    J Control Release; 2013 Dec; 172(2):568-78. PubMed ID: 23665254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between a 54-kilodalton mammalian cell surface protein and cowpea mosaic virus.
    Koudelka KJ; Rae CS; Gonzalez MJ; Manchester M
    J Virol; 2007 Feb; 81(4):1632-40. PubMed ID: 17121801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A co-formulated vaccine of irradiated cancer cells and cowpea mosaic virus improves ovarian cancer rejection.
    Zhao Z; Ortega-Rivera OA; Chung YH; Simms A; Steinmetz NF
    J Mater Chem B; 2023 Jun; 11(24):5429-5441. PubMed ID: 36861401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical addressability of ultraviolet-inactivated viral nanoparticles (VNPs).
    Rae C; Koudelka KJ; Destito G; Estrada MN; Gonzalez MJ; Manchester M
    PLoS One; 2008 Oct; 3(10):e3315. PubMed ID: 18830402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unique potency of Cowpea mosaic virus (CPMV)
    Shukla S; Wang C; Beiss V; Cai H; Washington T; Murray AA; Gong X; Zhao Z; Masarapu H; Zlotnick A; Fiering S; Steinmetz NF
    Biomater Sci; 2020 Sep; 8(19):5489-5503. PubMed ID: 32914796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.